Latest Breaking News On - Michelle greenblatt - Page 6 : comparemela.com

argenx Announces Validation of European Marketing

argenx Announces Validation of European Marketing
globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.

United statesKelsey kirkMichelle greenblattBeth delgiaccoTim van hauwermeirenAndreas meiselDepartment of neurologyDrug administrationEuropean medicines agencyDevices agencyJapan pharmaceuticalsImmunology innovation programChief executive officerSenior physicianMyasthenia gravis outpatient clinicPrincipal investigator

argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference

Press release content from Globe Newswire. The AP news staff was not involved in its creation. argenx to Present at 2021 Wedbush PacGrow Virtual Healthcare Conference argenx SEAugust 4, 2021 GMT August 4, 2021 Breda, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that members of management will participate in a fireside chat at the 2021 Wedbush PacGrow Virtual Healthcare Conference on Wednesday, August 11, 2021 at 11:30 a.m. ET. A live webcast of the presentation may be accessed on the Investors section of the argenx website at argenx.com/investors. A replay of the webcast will be available on the argenx website for approximately 90 days following the call.

United statesKelsey kirkMichelle greenblattBeth delgiaccoImmunology innovation programPacgrow virtual healthcare conferenceஒன்றுபட்டது மாநிலங்களில்கெல்ஸீ கர்க்நோயெதிர்ப்பு கண்டுபிடிப்பு ப்ரோக்ர்யாம்

argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021

argenx to Report Half Year 2021 Financial Results and Second Quarter Business Update on July 29, 2021
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomKelsey kirkMichelle greenblattBeth delgiaccoImmunology innovation programஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்கெல்ஸீ கர்க்நோயெதிர்ப்பு கண்டுபிடிப்பு ப்ரோக்ர்யாம்

argenx announces results of Annual General Meeting of Shareholders

Press release content from Globe Newswire. The AP news staff was not involved in its creation. argenx announces results of Annual General Meeting of Shareholders argenx SEMay 11, 2021 GMT May 11, 2021 Breda, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer, today announced that the proposed resolutions presented at its Annual General Meeting of Shareholders, held today at 10:00 a.m. CEST, were duly passed. As part of the approved resolutions: Yvonne Greenstreet has been appointed as non-executive director to the Board of Directors for a term of four (4) years;

United statesDavid laceyMichelle greenblattBeth delgiaccoYvonne greenstreetAnthony rosenbergImmunology innovation programAnnual general meetingஒன்றுபட்டது மாநிலங்களில்டேவிட் லேசிய்வாந் கிரீன்ஸ்ட்ரீட்நோயெதிர்ப்பு கண்டுபிடிப்பு ப்ரோக்ர்யாம்ஆண்டு ஜநரல் சந்தித்தல்

argenx to Report First Quarter 2021 Financial Results and Business Update on May 14, 2021

United States 1 844 808 7140 International 1 412 902 0128 About argenx argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases and cancer. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx is evaluating efgartigimod in multiple serious autoimmune diseases, and cusatuzumab in hematological cancers in collaboration with Janssen. argenx is also advancing several earlier stage experimental medicines within its therapeutic franchises. argenx has offices in Belgium, the United States, Japan and Switzerland. For more information, visit https://www.argenx.com/ and follow us on LinkedIn at https://www.linkedin.com/company/argenx/ and Twitter at https://twitter.com/argenxglobal.

United statesUnited kingdomKelsey kirkMichelle greenblattBeth delgiaccoImmunology innovation programஒன்றுபட்டது மாநிலங்களில்ஒன்றுபட்டது கிஂக்டம்கெல்ஸீ கர்க்நோயெதிர்ப்பு கண்டுபிடிப்பு ப்ரோக்ர்யாம்